Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$278.73 - $327.27 $3.23 Million - $3.79 Million
-11,576 Reduced 35.08%
21,427 $6.95 Million
Q1 2022

May 13, 2022

SELL
$234.69 - $291.66 $1.14 Million - $1.41 Million
-4,850 Reduced 12.81%
33,003 $9.45 Million
Q4 2021

Feb 14, 2022

SELL
$224.85 - $279.04 $2.05 Million - $2.55 Million
-9,126 Reduced 19.43%
37,853 $10.5 Million
Q3 2021

Nov 12, 2021

BUY
$221.6 - $272.71 $1.87 Million - $2.3 Million
8,445 Added 21.92%
46,979 $10.9 Million
Q2 2021

Aug 16, 2021

BUY
$180.55 - $233.54 $427,722 - $553,256
2,369 Added 6.55%
38,534 $8.84 Million
Q1 2021

May 17, 2021

SELL
$164.32 - $212.72 $58,497 - $75,728
-356 Reduced 0.97%
36,165 $6.76 Million
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $4.76 Million - $6.3 Million
36,521 New
36,521 $6.17 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $743B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Socorro Asset Management LP Portfolio

Follow Socorro Asset Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Socorro Asset Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Socorro Asset Management LP with notifications on news.